Canaccord lowered the firm’s price target on UiPath (PATH) to $15 from $16 and keeps a Buy rating on the shares. The firm said UiPath demonstrated improving execution and early signs of building momentum selling agentic capabilities in its FQ2’26 with revenue of $362M, stable NRR at 108%, and non-GAAP operating income of $62M. The results, while not world-beating, demonstrate stability including some growth green shoots with large global enterprises while continuing to highlight strong profitability with a 25% TTM adjusted Free Cash Flow margin.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- Daré, AMD, Twilio, UiPath, Luckin: Trending by Analysts
- UiPath Inc: Strong Earnings Amid Macroeconomic Challenges
- UiPath price target lowered to $12.50 from $15.50 at BMO Capital
- UiPath price target lowered to $12 from $13 at Truist
- UiPath: Stabilization Amidst Challenges and Future Growth Potential – Hold Rating